Skip to main content

Table 3 Classification of the F 2 siblings obtained from Crosses I and II

From: Reassessment of the function of somatolactin alpha in lipid metabolism using medaka mutant and transgenic strains

Genotypes of the Cross I siblings

Phenotypes of the siblings*

[Ci/Ci; B/b; R/r; SLa+/SLa], [Ci/ci; B/b; R/r; SLa+/SLa]

black, orange, SLa++

[Ci/Ci; B/b; R/r; SLa/SLa], [Ci/ci; B/b; R/r; SLa/SLa]

black, orange, SLa+

[Ci/Ci; B/b; r/r; SLa+/SLa], [Ci/ci; B/b; r/r; SLa+/SLa]

black, SLa++

[Ci/Ci; B/b; r/r; SLa/SLa], [Ci/ci; B/b; r/r; SLa/SLa]

black, SLa+

[Ci/Ci; b/b; R/r; SLa+/SLa], [Ci/ci; b/b; R/r; SLa+/SLa]

orange, SLa++

[Ci/Ci; b/b; R/r; SLa/SLa], [Ci/ci; b/b; R/r; SLa/SLa]

orange, SLa+

[Ci/Ci; b/b; r/r; SLa+/SLa], [Ci/ci; b/b; r/r; SLa+/SLa]

SLa++

[Ci/Ci; b/b; r/r; SLa/SLa], [Ci/ci; b/b; r/r; SLa/SLa]

SLa+

Genotypes of the Cross II siblings

Phenotypes of the siblings*

[Ci/ci; B/B; R/R; SLa+/SLa], [Ci/ci; B/B; R/r; SLa+/SLa],

black, orange, SLa++

[Ci/ci; B/b; R/R; SLa+/SLa], [Ci/ci; B/b; R/r; SLa+/SLa],

[ci/ci; B/B; R/R; SLa+/SLa], [ci/ci; B/B; R/r; SLa+/SLa],

[ci/ci; B/b; R/R; SLa+/SLa], [ci/ci; B/b; R/r; SLa+/SLa]

[Ci/ci; B/B; R/R; SLa/SLa], [Ci/ci; B/B; R/r; SLa/SLa],

black, orange, SLa+

[Ci/ci; B/b; R/R; SLa/SLa], [Ci/ci; B/b; R/r; SLa/SLa]

[ci/ci; B/B; R/R; SLa/SLa], [ci/ci; B/B; R/r; SLa/SLa],

black, orange, SLa

[ci/ci; B/b; R/R; SLa/SLa], [ci/ci; B/b; R/r; SLa/SLa]

 
  1. *: SLa++ overexpression, SLa+ normal expression, SLa no expression. SLa expression from the wild-type Ci allele is negligible when the exogenous SLa gene is present.